New guidance to help the NHS and the pharmaceutical industry work successfully together.
Pharmaceutical companies are doing everything in their power to avoid disruption to the supply of medicines in all Brexit scenarios. This includes increasing stocks of medicine in the UK, changing supply routes, transferring medicine licenses and duplicating testing in the EU.
The UK has robust measures in place to ensure that medicines and vaccines are both clinically and cost effective before they can be used in the NHS.
Illness never sleeps. It grows, mutates and causes pain and suffering. Disease never takes a break, so neither do we. Because people fighting disease deserve the best chance to live. We won’t rest until people around the world see a brighter tomorrow.
The ABPI has produced this sourcebook to support pharmaceutical companies in working successfully and collaboratively with patients and patient organizations.
The UK Life Sciences Industrial Strategy should be required reading for every healthcare leader in the UK. It makes clear that the NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes.
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.
17 September 2019
A new collaboration to tackle the biggest health challenges faced by the West Midlands’ six million residents will use real-time clinical trials and health data to speed up research and improve cancer care, maternity services, child health, obesity, and dementia.
12 September 2019
Government has published the documents relating to 'Operation Yellowhammer' with planning assumptions for a 'no-deal' Brexit.
12 September 2019
Health Data Research UK has announced the locations of seven new digital innovation hubs that will help the UK make the most of health-related data for future research and development into new medicines.
10 September 2019
Public Health England has published its evidence review of dependence and withdrawal problems associated with five commonly prescribed classes of medicines in England.
03 September 2019
19 August 2019
The Prime Minister has demanded urgent action to tackle declining vaccination rates for MMR. This is the right approach, says Dr Sheuli Porkess of the ABPI.